Showing results (101-110 of 289) with videos related to
Sort By:
Pageof 29
In Vitro|September 1, 1982
Characterization of a new human cell line derived from a xenografted embryonal carcinomaC Cotte, D Raghavan, R A McIlhinney, et al.Langmuir : the ACS Journal of Surfaces and Colloids|October 7, 2005
Wetting-dewetting transition line in thin polymer filmsK M Ashley, D Raghavan, J F Douglas, et al.Seminars in Oncology|December 1, 1996
Management of hormone-resistant prostate cancer: an Australian trialD Raghavan, G Coorey, M Rosen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2014
Adjuvant chemotherapy for bladder cancer-why does level 1 evidence not support it?D Raghavan, A Bawtinhimer, J Mahoney, et al.European Journal of Cancer & Clinical Oncology|January 1, 1986
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantreneA S Coates, J Bishop, G J Mann, et al.Journal of Neural Engineering|January 21, 2011
Automated spike sorting algorithm based on Laplacian eigenmaps and k-means clusteringE Chah, V Hok, A Della-Chiesa, et al.British Journal of Cancer|July 1, 1981
Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodiesV Moshakis, R A McIlhinney, D Raghavan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Hypercholesterolemia after chemotherapy for testis cancerD Raghavan, K Cox, A Childs, et al.British Journal of Cancer|September 27, 2012
Recruitment of ethnic minorities into cancer clinical trials: experience from the front linesR P Symonds, K Lord, A J Mitchell, et al.Urologic Oncology|May 10, 2001
Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression. a review of the evidenceS R. Downing, P Jackson, P J. RussellPageof 29